DMway Analytics Offers Its AUTO-ML Platform Free of Charge to Every Ministry of Health Department and Covid-19 Research Center Globally

JERUSALEM, March 30, 2020 /PRNewswire/ — DMway analytics, leading provider of machine learning automation platforms, announced today it was offering its predictive analytics and automated ML platform to every Ministry of Health department globally. In the USA this includes all State level authorities and elsewhere the equivalent.

The DMway (www.dmway.com) Auto-ML platform is developed by leading Ph.D.s in the field of auto-machine learning and data science, and can transform non-scientists (analysts, BI and data experts) into capable, insightful Data Science Citizens. In practical terms this means that the analysis of Covid-19 data that can currently be carried out by very few people, can now be carried out by many. We are weaponizing Data Science automation to fight back against the virus.

Machine learning and predictive analytics are going to be key in winning the Covid-19 battle. That much is clear. Analyzing data is essential in being able to understand the spread and treatment effectiveness. The world needs many more people analyzing the data. The insight from global information on the spread of the virus and its behavior will be key in minimizing the damage. The ability to empower thousands of citizen data scientists could potentially revolutionize the speed at which we can react to data as it is made available.

Gil Nizri, DMway analytics CEO, said: “The time is right for technology leaders to donate as much as they can to help the world in confronting this invisible and brutal enemy. We have invested millions of dollars in our tool, but free access at this critical time is essential. Machine learning will be a key tool in dealing with Covid-19. We cannot see the use of machine learning restricted to a few individuals with access and knowledge of machine learning tools. We hope the DMway tool will be used to empower thousands of relevant people to analyze Covid-19 related data. It is simple to learn, and we will train people en-masse of up to 100 at a time via video link from our HQ here in Israel.” Nizri added, “Our machine learning for Covid-19 course has been especially carted this past two weeks and adjusted to biologists, epidemic analysts and healthcare data experts. Covid-19 is the enemy. Let us fight this together. A global team against this killer.”

For further information: Gil Nizri,CEO, gil@dmway.com

 

View original content:http://www.prnewswire.com/news-releases/dmway-analytics-offers-its-auto-ml-platform-free-of-charge-to-every-ministry-of-health-department-and-covid-19-research-center-globally-301031518.html

SOURCE DMWay Analytics

Staff

Recent Posts

Evotec Closes Sale of Just – Evotec Biologics’ Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing…

2 hours ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

5 hours ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

5 hours ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

20 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

20 hours ago